Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1990-09-20
1993-09-14
Chambers, Jasemine C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4352402, 4353201, 435 691, 435 703, 435 711, 4351723, 4352542, 536 2372, 935 12, 935 69, 935 70, 424 89, C12P 2106, C12N 500, C12N 1500, C07H 2100
Patent
active
052447928
ABSTRACT:
The glycoprotein B ("gB") and functional fragments thereof are provided by recombinant DNA technology. Oligonucleotide sequences are provided coding the glycoprotein, its precursor and fragments thereof. Methods and compositions are disclosed for the production of the glycoprotein and functional fragments thereof as well as oligonucleotide sequences, which may be used for probes or other applications, and particularly may be used for vaccines. The following E. coli HB101 strains were deposited at the A.T.C.C. on April 4, 1984, where the plasmid indicates the plasmid employed to transform the strain; pHS112; pHS114 (gB1 mammalian); pHS127A (gB1 yeast); pHS203; and pHS206 (gB2), and assigned Accession Nos. 39649-39653, respectively, where the nature of the plasmid is indicated in parentheses and the number refers back to the number employed in the Experimental section.
REFERENCES:
patent: 4317811 (1982-03-01), Bertland et al.
patent: 4374127 (1983-02-01), Larson et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4724146 (1988-02-01), Kino et al.
Hitzeman et al., Nucl. Acid Res. 11:2745 (1983).
Ringold et al., J. Mol. Appl. Genet. 1:165-175 (1981).
McAleer et al., Nature 307:178 (1984).
Arsenakis et al., J. Virslogy 60:674-682 (1986).
Michel et al., Proc. Natl. Acad. Sci. 81:7708-12 (1984).
Valenzuela et al., Nature 298:347 (1982).
Miyanohara et al., Proc. Natl. Acad. Sci. 80:1-5 (1983).
DeLucca et al., Virology 122:411-23 (1982).
Eberle et al., (1983) J. of Infectious Diseases 148:436-444.
Marsden et al., (1978) J. of Virology 28:624-642.
Ruyechan et al., (1979) J. of Virology 29:677-697.
Skare et al., (1977) Virology 76:581-595.
Roizman, (1979) Ann. Rev. Genetics 13:25-57.
Hilfenhaus et al., (1982) Develop. Biol. Standard 52:321-331.
Weis et al., (1983) Nature 302:72-74.
Lasky et al., (Jun. 1984) Biotechnology P. 527-532.
Berman et al., (1985) Science 227:1490-1492.
Cappel et al., (1985) J. Medical Virol. 16:137-145.
Dundarov et al., (1982) Dev. Biol. Standard 52:351-357.
Skinner et al., (1982) Dev. Biol. Standard 52:333-344.
Watson et al., (1982) Science 218:381-384.
Cohen et al., (1984) J. Virology 49:102-108.
Chan, (1983) Immunology 49:343-352.
Journal of Virology Jan. 1985 vol. 53 No. 1 pp. 243-253.
Virology vol. 133, pp. 301-314 (1984).
Burke Rae L.
Pachl Carol
Valenzuela Pablo D. T.
Chambers Jasemine C.
Chiron Corporation
McClung Barbara G.
Robins Roberta L.
LandOfFree
Expression of recombinant glyoprotein B from herpes simplex viru does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression of recombinant glyoprotein B from herpes simplex viru, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of recombinant glyoprotein B from herpes simplex viru will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2025908